On the Prognostic Implication of Delays in the Definitive Treatment of Uveal Melanoma
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Timely treatment of uveal melanoma is crucial. Delays can increase the risk of metastasis, as new evidence suggests later seeding and additional genetic mutations in tumors.
Area Of Science
- Ophthalmology
- Oncology
- Medical Research
Background
- Uveal melanoma treatment timing is debated.
- Delays in definitive treatment may elevate metastatic risk.
Purpose Of The Study
- To clarify the association between treatment delays and uveal melanoma prognosis.
- To synthesize evidence on metastatic seeding and tumor progression.
Main Methods
- Review and synthesis of recent medical evidence.
- Comparative analysis of studies on uveal melanoma treatment and outcomes.
Main Results
- Metastatic seeding can occur until the primary uveal melanoma is treated.
- Later-stage genetic aberrations in metastases can enhance their lethality.
- Local tumor recurrence correlates with increased metastasis risk.
- New data on circulating tumor cells challenge observation for small melanomas.
Conclusions
- Observation is appropriate for indeterminate lesions to confirm malignancy.
- Once uveal melanoma is diagnosed, delaying treatment is detrimental.
- Prompt administration of treatment is recommended after diagnosis.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
